Steven Davis, MD
Dermatology · San Antonio, TXNPI 1861431025
Payments from drug & device makers
Across 726 payments — averaging $2475.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$400K
- Eli Lilly$266K
- AbbVie$264K
- E.r. Squibb & Sons, L.L.C.$208K
- Amgen$198K
- Pfizer$161K
- plus $300K from 19 others
Across 50 payments — averaging $2649.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$91K
- E.r. Squibb & Sons, L.L.C.$16K
- Sanofi US Services Inc.$14K
- Eli Lilly$9K
- Regeneron$1K
- Galderma Laboratories, L.p.$750
- plus $439 from 1 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 265 | $400,348 |
| Eli Lilly | 35 | $266,369 |
| AbbVie | 115 | $263,992 |
| E.r. Squibb & Sons, L.L.C. | 13 | $207,841 |
| Amgen | 16 | $198,073 |
| Pfizer | 70 | $160,877 |
| Janssen Research & Development, LLC | 15 | $68,631 |
| Journey Medical Corporation | 5 | $66,875 |
| Sun Pharmaceutical Industries Inc. | 24 | $48,761 |
| Regeneron | 26 | $45,185 |
| Dr.reddy's Laboratories,inc. | 7 | $18,781 |
| Dermavant Sciences, Inc. | 114 | $18,126 |
| VYNE Pharmaceuticals Inc. | 2 | $13,182 |
| Kyowa Kirin Pharmaceutical Development, Inc | 1 | $10,000 |
| Novartis | 2 | $5,063 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $4,000 |
| Galderma Research & Development, LLC | 1 | $493 |
| Boehringer Ingelheim | 1 | $300 |
| Galderma Laboratories, L.p. | 1 | $205 |
| Johnson & Johnson | 2 | $172 |
| Krystal Biotech Inc | 3 | $86 |
| Lilly USA, LLC | 3 | $73 |
| Optos, Inc. | 1 | $22 |
| Botanix SB Inc | 1 | $22 |
| Sanofi | 1 | $17 |
How this compares
$1,797,495 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in San Antonio
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Emily BeckerSan Antonio$2.4M
- William CragunSan Antonio$2.3M
- Lindsey FinkleaSan Antonio$1.2M
- Stephen MillerSan Antonio$389K
- Vivian BucaySan Antonio$241K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Craig TellerBellaire$7.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.